# common_lang/en - cl - common to all products, language specific - many mandatory
# all key names are reserved
lang=en
ph=place holder
paediatric=Paediatric population
annex_i=Annex I
annex_ii=Annex II
annex_iii=Annex III
sec_moni_c=This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
spc=Summary of product characteristics
sec_name_1=Name of the medicinal product
sec_name_2=Qualitative and quantitative composition
sub_name_2_1=General description
sub_name_2_2=Qualitative and quantitative composition
excipient_effect=Excipient(s) with known effect
excipient_see=For the full list of excipients, see section 6.1.
sec_name_3=Pharmaceutical form
sec_3_break=The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
sec_3_nobreak=The score line is not intended for breaking the tablet.
sec_3_equal=The tablet can be divided into equal doses.
sec_name_4=Clinical particularS
sub_name_4_1=Therapeutic indications
sub_4_1_dia=This medicinal product is for diagnostic use only.
sub_4_1_indi=is indicated in (neonates|infants|children|adolescents|adults) (aged [0-130] to [1-130] (years|months))
sub_name_4_2=Posology and method of administration
ssu_name_4_2_1=Posology
ssu_name_4_2_3=Method of administration
sub_name_4_3=Contraindications
sub_name_4_4=Special warnings and precautions for use
ssu_name_4_4_1=Traceability
sub_name_4_5=Interaction with other medicinal products and other forms of interaction
sub_name_4_6=Fertility, pregnancy and lactation
ssu_name_4_6_1=Pregnancy
ssu_name_4_6_2=Breast-feeding
ssu_name_4_6_3=Fertility
sub_name_4_7=Effects on ability to drive and use machines
sub_name_4_8=Undesirable effects
sub_name_4_9=Overdose
sec_name_5=Pharmacological properties
sub_name_5_1=Pharmacodynamic properties
sub_name_5_2=Pharmacokinetic properties
ssu_name_5_2_1=Absorption
ssu_name_5_2_2=Distribution
ssu_name_5_2_3=Biotransformation
ssu_name_5_2_4=Elimination
ssu_name_5_2_5=Linearity/non-linearity
ssu_name_5_2_6=Renal impairment
ssu_name_5_2_7=Hepatic impairment
ssu_name_5_2_8=Elderly
ssu_name_5_2_9=Paediatric population
ssu_name_5_2_10=Other special populations
ssu_name_5_2_11=Pharmacokinetic/pharmacodynamic relationship(s)
sub_name_5_3=Preclinical safety data
ssu_name_5_3_1=Environmental risk assessment (ERA)
sec_name_6=Pharmaceutical particulars
sub_name_6_1=List of excipients
sub_name_6_2=Incompatibilities
sub_name_6_3=Shelf life
sub_name_6_4=Special precautions for storage
# (pattern)? in regular expression means optional - '?': zero or one time
# https://en.wikipedia.org/wiki/Regular_expression
sub_name_6_5=Nature and contents of container( and special equipment for use, administration or implantation)?
sub_name_6_6=Special precautions for disposal( and other handling)?
sec_name_7=Marketing authorisation holder
sec_name_8=Marketing authorisation number(s)
sec_name_9=Date of first authorisation/renewal of the authorisation
sec_name_10=Date of revision of the text
sec_name_11=Dosimetry
sec_name_12=Instructions for preparation of radiopharmaceuticals